Top Authors

• Most frequent coverage on GERN

• 
  Mike Havrilla (1933 followers)

  • BioMed Momentum Index: A Pause that Refreshes or More Pain to Come? (Thu, Oct 29)
  • Stem Cell Index Surges in Past Week (Mon, May 11)
  • Cytori Therapeutics: Natural Play on Cosmetic Medicine (Mon, Mar 2)

  More by Mike Havrilla on GERN »
• 
  Frederic Ruffy (600 followers)

  • Wednesday Options Recap (Wed, Dec 2)
  • Tuesday Options Recap (Tue, Aug 18)
  • Thursday's Options Recap (Thu, May 21)

  More by Frederic Ruffy on GERN »
• 
  SA Editor Miriam Metzinger (539 followers)

  • Cramer's Lightning Round - Energy Transfer Partners Is an Armored Stock (10/1/09) (Fri, Oct 2)
  • Cramer's Lightning Round - BAC Is Back (7/27/09) (Tue, Jul 28)
  • Cramer's Mad Money - Follow That Hedge Fund (5/20/09) (Thu, May 21)

  More by SA Editor Miriam Metzinger on GERN »

• Most followed authors on GERN

• 
  SA Editor Rachael Granby (2022 followers)

  • Wall Street Breakfast: Must-Know News (Fri, Jul 31)
  • Wall Street Breakfast: Must-Know News (Tue, Mar 10)
  • Wall Street Breakfast: Must-Know News (Fri, Feb 27)

  More by SA Editor Rachael Granby on GERN »
• 
  Mike Havrilla (1933 followers)

  • BioMed Momentum Index: A Pause that Refreshes or More Pain to Come? (Thu, Oct 29)
  • Stem Cell Index Surges in Past Week (Mon, May 11)
  • Cytori Therapeutics: Natural Play on Cosmetic Medicine (Mon, Mar 2)

  More by Mike Havrilla on GERN »
• 
  Andrew Wilkinson (1162 followers)

  • Tuesday Options Update: ELX, GERN, VALE, NVDA & EXC (Tue, Jun 30)

  More by Andrew Wilkinson on GERN »

• Newest authors on GERN

• 
  Bryan Gomez (39 followers)

  • Megatrend Companies Summary (Thu, Sep 10)
  • A Guide to Investing in the Next Decade (Thu, Aug 27)

  More by Bryan Gomez on GERN »
• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on GERN »
• 
  Beacon Asset Managers (131 followers)

  • Geron Pushes Higher on GE Healthcare Alliance (Wed, Jul 1)
  • Geron's Risk-Reward Profile - Best in Biotech? (Fri, Jun 12)

  More by Beacon Asset Managers on GERN »

• Most commented on GERN

• 
  SA Editor Rachael Granby (2022 followers)

  • Wall Street Breakfast: Must-Know News (Fri, Jul 31)
  • Wall Street Breakfast: Must-Know News (Tue, Mar 10)
  • Wall Street Breakfast: Must-Know News (Fri, Feb 27)

  More by SA Editor Rachael Granby on GERN »
• 
  Andrew Mickey (861 followers)

  • Where the Big Money Is Betting Big (Fri, May 15)
  • Stem Cell Research: The Next Boom? (Sat, Nov 22)

  More by Andrew Mickey on GERN »
• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)

  More by Justin M. Hall on GERN »